Intra-arterial virus and nonvirus vector-mediated gene transfer to experimental rat brain tumors

Frontiers of Radiation Therapy and Oncology

Volumn 33, Issue , 1999, Pages 227-240

  Rainov, Nikolai G ^a   Ikeda, Keiro ^b   Qureshi, Nazir ^b   Grover, Shivani ^b   Barnett, Faith H ^b,c   Herrlinger, Ulrich ^b,c   Quinones, Ariel ^a   Chiocca, E Antonio ^b   Breakefield, Xandra O ^b,c  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRADYKININ; DNA; LIPOSOME;

ADENOVIRUS; ANIMAL; ARTICLE; BLOOD BRAIN BARRIER; BRAIN TUMOR; FISCHER 344 RAT; GENE TRANSFER; GENE VECTOR; GENETICS; INTRAARTERIAL DRUG ADMINISTRATION; MALE; RAT; VASCULARIZATION;

ADENOVIRIDAE; ANIMALS; BLOOD-BRAIN BARRIER; BRADYKININ; BRAIN NEOPLASMS; DNA; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; INJECTIONS, INTRA-ARTERIAL; LIPOSOMES; MALE; RATS; RATS, INBRED F344;

EID: 0032677622     PISSN: 00719676     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000061238     Document Type: Article

References (42)

1. Badie B, Drazan KE, Kramar MH, Shaked A, Black KL: Adenovirus-mediated p53 gene delivery inhibits 9L glioma growth in rats. Neurol Res 1995;17:209-216.
2. Behr TP, Demeneix B, Loeffler JP, Perez-Mutul J: Efficient gene transfer into mammalian primary endocrine cells with lipopolyamine-coated DNA. Proc Natl Acad Sci USA 1989;86:6982-6986.
3. Berens ME, Rutka JT, Rosenblum ML: Brain tumor epidemiology, growth, and invasion. Neurosurg Clin North Am 1990;1:1-18.
4. Boucher Y, Leunig M, Jain RK: Tumor angiogenesis and interstitial hypertension. Cancer Res. 1996;56:4264-4266.
5. Boviatsis EJ, Chase M, Wei M, Tamiya T, Hurford RK Jr, Kowall NW, Tepper RI, Breakefield XO, Chiocca EA: Gene transfer into experimental brain tumors mediated by adenovirus, herpes simplex virus (HSV), and retrovirus vectors. Hum Gene Therapy 1994a;5:183-191.
6. Boviatsis EJ, Park JS, Sena-Esteves M, Kramm CM, Chase M, Efird JT, Wei MX, Breakefield XO, Chiocca EA: Long-term survival of rats harboring brain neoplasms treated with ganciclovir and a herpes simplex virus vector that retains an intact thymidine kinase gene. Cancer Res 1994b;54:5745-5751.
7. Byrnes AP, MacLaren RE, Charlton HM: Immunological instability of persistent adenovirus vector in the brain: Peripheral exposure to vector leads to renewed inflammation, reduced gene expression and demyelination. J Neurosci 1996;16:3045-3055.
8. Chen SH, Shine HD, Goodman JC, Grossman RG, Woo SL: Gene therapy for brain tumors: regression of experimental gliomas by adenovirus mediated gene transfer in vivo. Proc Natl Acad Sci USA 1994;91:3054-3057.
9. Chen X, Li Y, Xiong K, Xie Y, Aizicovici S, Snodgrass R, Wagner TE, Platika D: A novel nonviral cytoplasmic gene expression system and its implications in cancer gene therapy. Cancer Gene Ther 1995;2:281-289.
10. Chiocca EA, Andersen J, Takamiya Y, Martuza R, Breakefield XO: Virus-mediated genetic treatment of rodent gliomas; in Wolf JA (ed): Gene Therapeutics. Boston, Birkhauser, 1994, pp 245-262.
11. Cox DJ, Pilkington GJ, Lantos PL: The fine structure of blood vessels in ethylnitrosurea-induced tumours of the rat nervous system: With special reference to the breakdown of the blood-brain barrier. Br J Exp Pathol 1976;57:419-430.
12. Curiel DT: High efficiency gene transfer mediated by adenovirus-polylysine-DNA complexes. Ann NY Acad Sci 1994;716:36-57.
13. Doran SE, Dan Ren X, Betz AL, Pagel MA, Neuwelt EA, Roessler BJ, Davidson BL: Gene expression from recombinant viral vectors in the CNS following blood-brain barrier disruption. Neurosurgery 1995;36:965-970.
14. Eck SL, Alavi JB, Alavi A, Davis A, Hackney D, Judy K, Mollman J, Phillips PC, Wheeldon EB, Wilson JM: Treatment of advanced CNS malignancies with the recombinant adenovirus H5.010RSVTK: A phase I trial. Hum Gene Ther 1996;7:1465-1482.
15. Elliott PJ, Hayward NJ, Huff MR, Nagle TL, Black KL, Bartus RT: Unlocking the blood-brain barrier: A role for RMP-7 in brain tumor therapy. Exp Neurol 1996;141:214-224.
16. Felgner JH, Kumar R, Sridhar CN, Wheeler CJ, Tsai YJ, Border R, Ramsey P, Martin M, Felgner PL: Enhanced gene delivery and mechanism studies with a novel series of cationic lipid formulations. J Biol Chem 1994;269:2550-2561.
17. Felgner PL, Tsai YJ, Sukhu L, Wheeler CJ, Manthorpe M, Marshall J, Cheng H: Improved cationic lipid formulations for in vivo gene therapy. Ann NY Acad Sci 1995;772:126-139.
18. Fritz JD, Herwejer H, Zhang G, Wolff JA: Gene transfer into mammalian cells using histone-condensed plasmid DNA. Hum Gene Ther 1996;7:1395-1404.
19. Hess JF,Borkowski JA,Young GS, Strader CD,Ransom RW: Cloningandpharmacological characterization of a human bradykinin (BK-2) receptor. Biochem Biophys Res Commun 1992;184:260-268.
20. Hoshino T: A commentary on the biology and growth kinetics of low-grade and high-grade gliomas. J Neurosurg 1984;61:895-900.
21. Huard J, Lochmuller H, Acsadi G, Jani A, Massie B, Karpati G: The route of administration is a major determinant of the transduction efficiency of rat tissues by adenoviral recombinants. Gene Ther 1995;2:107-115.
22. Hug P, Sleight RG: Liposomes for the transformation of eukaryotic cells. Biochim Biophys Acta 1991;1097:1-17.
23. Inamura T, Black KL: Bradykinin selectively opens blood-tumor barrier in experimental brain tumors. J Cereb Blood Flow Metab 1994;14:862-870.
24. Kramm CM, Rainov NG, Sena-Esteves M, Barnett FH, Chase M, Herrlinger U, Pechan PA, Chiocca EA, Breakefield XO: Long-term survival in a rodent model of disseminated brain tumors by combined intrathecal delivery of herpes vectors and ganciclovir treatment. Hum Gene Ther 1996;7:1989-1994.
25. Kramm CM, Sena-Esteves M, Barnett FH, Rainov NG, Schuback DE, Yu JS, Pechan PA, Paulus W, Chiocca EA, Breakefield XO: Gene therapy for brain tumors. Brain Pathol 1995;5:345-381.
26. Maron A, Gustin T, Le-Roux A, Mottet I, Dedieu JF, Brion JP, Demeure R, Perricaudet M, Octave JN: Gene therapy of rat C6 glioma using adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene: Long-term follow-up by magnetic resonance imaging. Gene Ther 1996;3:315-322.
27. Michael SI, Curiel DT: Strategies to achieve gene delivery via the receptor-mediated endocytosis pathway. Gene Ther 1994;1:223-232.
28. Neuwelt EA, Pagel MA, Dix RD: Delivery of ultraviolet inactivated 35S-herpesvirus across an osmotically modified blood-brain barrier. J Neurosurg 1991;74:475-479.
29. Nilaver G, Muldoon LL, Kroll RA, Pagel MA, Breakefield XO, Davidson BL, Neuwelt EA: Delivery of herpesvirus and adenovirus to nude rat intracerebral tumors following osmotic blood-brain barrier disruption. Proc Natl Acad Sci USA 1995;92:9829-9833.
30. Perez-Cruet MJ, Trask TW, Chen SH, Goodman JC, Woo SL, Grossman RG, Shine HD: Adenovirusmediated gene therapy of experimental gliomas. J Neurosci Res 1994;39:506-511.
31. Rainov NG, Dobberstein KU, Heidecke V, Dorant U, Chase M, Kramm CM, Chiocca EA, Breakefield XO: Long-term survival in a rodent brain tumor model by bradykinin-enhanced intra-arterial delivery of a therapeutic herpes simplex virus vector. Cancer Gene Ther 1998;5:158-162.
32. Rainov NG, Zimmer C, Chase M, Kramm CM, Chiocca EA, Weissleder R, Breakefield XO: Selective uptake of viral and monocrystalline particles delivered intra-arterially to experimental brain neoplasms. Hum Gene Ther 1995;6:1543-1552.
33. San H, Yang ZY, Pompili VJ, Jaffe ML, Plautz GE, Xu L, Felgner JH, Wheeler CJ, Felgner PL, Gao X, et al: Safety and short-term toxicity of a novel cationic lipid formulation for human gene therapy. Hum Gene Ther 1993;4:781-788.
34. Schofield JP, Caskey CT: Nonviral approaches to gene therapy. Brit Med Bull 1995;51:56-71.
35. Stephan DJ, Yang ZY, San H, Simari RD, Wheeler CJ, Felgner PL, Gordon D, Nabel GJ, Nabel EG: A new cationic liposome DNA complex enhances the efficiency of arterial gene transfer in vivo. Hum Gene Ther 1996;7:1803-1812.
36. Tomita N, Morishita R, Higaki J, Tomita S, Aoki M, Ogihari T, Kaneda Y: In vivo gene transfer of insulin gene into neonatal rats by the HIV-liposome method resulted in sustained gene expression. Gene Ther 1996;3:477-482.
37. Turner DL, Snyder EY, Cepko CL: Lineage-independent determination of cell type in the embryonic mouse retina. Neuron 1990;4:833-845.
38. Vincent AJ, Vogels R, Someren GV, Esandi MC, Noteboom JL, Avezaat CJ, Vecht C, Bekkum DW, Valerio D, Bout A, Hoogerbrugge PM: Herpes simplex virus thymidine kinase gene therapy for rat malignant brain tumors. Hum Gene Ther 1996;7:197-205.
39. Viola JJ, Ram Z,Walbridge S, Oshiro EM, Trapnell B, Tao-Cheng JH, Oldfield EH: Adenovirally mediated gene transfer into experimental solid brain tumors and leptomeningeal cancer cells. J Neurosurg 1995;82:70-76.
40. Yoshida J, Mizzuno M: Simple method to prepare cationicmultilamellar liposomes for efficient transfection of human interferon-b gene to human glioma cells. J Neurooncol 1994;19:269-274.
41. Zerrouqi A, Rixe O, Ghoumari AM, Yarovoi SV, Mouawad R, Khayat D, Soubrane C: Liposomal delivery of the herpes simplex virus thymidine kinase gene in glioma: Improvement of cell sensitization to ganciclovir. Cancer Gene Ther 1996;3:385-392.
42. Zhu J, Zhang L, Hanisch UK, Felgner PL, Reszka R: A continuous intracerebral gene delivery system for in vivo liposome-mediated gene therapy. Gene Ther 1996;3:472-476.